diclofenac has been researched along with Macular Edema in 36 studies
Diclofenac: A non-steroidal anti-inflammatory agent (NSAID) with antipyretic and analgesic actions. It is primarily available as the sodium salt.
diclofenac : A monocarboxylic acid consisting of phenylacetic acid having a (2,6-dichlorophenyl)amino group at the 2-position.
Macular Edema: Fluid accumulation in the outer layer of the MACULA LUTEA that results from intraocular or systemic insults. It may develop in a diffuse pattern where the macula appears thickened or it may acquire the characteristic petaloid appearance referred to as cystoid macular edema. Although macular edema may be associated with various underlying conditions, it is most commonly seen following intraocular surgery, venous occlusive disease, DIABETIC RETINOPATHY, and posterior segment inflammatory disease. (From Survey of Ophthalmology 2004; 49(5) 470-90)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Patients preoperatively treated with diclofenac had significantly lower intraocular levels of IL-12 and a lower increase in CFT, which indicates that a combination of preoperative and postoperative treatment with a topical NSAID may lower the incidence of postoperative macular edema in patients with diabetic retinopathy." | 9.24 | Effect of preoperative topical diclofenac on intraocular interleukin-12 concentration and macular edema after cataract surgery in patients with diabetic retinopathy: a randomized controlled trial. ( Jukić, T; Matas, A; Medić, A; Sapunar, A; Vukojević, K; Znaor, L, 2017) |
| "The purpose of the study is to compare single injection of intravitreal diclofenac (IVD) with intravitreal bevacizumab (IVB) in the treatment of eyes with naïve diabetic macular edema (DME)." | 9.20 | Intravitreal diclofenac versus intravitreal bevacizumab in naive diabetic macular edema: a randomized double-masked clinical trial. ( Karimi, S; Montahai, T; Peyman, GA; Ramezani, A; Soheilian, M; Soheilian, R; Yaseri, M, 2015) |
| "To compare the effect of intravitreal diclofenac (IVD) versus intravitreal triamcinolone (IVT) on refractory uveitic cystoid macular edema (CME)." | 9.17 | A pilot study of intravitreal diclofenac versus intravitreal triamcinolone for uveitic cystoid macular edema. ( Eskandari, A; Rabbanikhah, Z; Ramezani, A; Soheilian, M; Soheilian, R, 2013) |
| "To compare the efficacy and safety of intravitreal diclofenac versus intravitreal triamcinolone acetonide in the treatment of diabetic macular edema." | 9.15 | Intravitreal diclofenac versus intravitreal triamcinolone acetonide in the treatment of diabetic macular edema. ( Elbendary, AM; Shahin, MM, 2011) |
| "The purpose of this study was to evaluate the effect of a single dose of intravitreal diclofenac, a potent nonsteroidal antiinflammatory drug, on visual acuity and central macular thickness in patients with macular edema of various etiologies." | 9.14 | Pilot study of intravitreal injection of diclofenac for treatment of macular edema of various etiologies. ( Karimi, S; Peyman, GA; Ramezani, A; Soheilian, M, 2010) |
| "This study compares the effect of topical diclofenac with that of betamethasone against postoperative cystoid macular edema (CME) following cataract surgery in patients with non- and mild nonproliferative diabetic retinopathy." | 9.12 | Diclofenac prevents an early event of macular thickening after cataract surgery in patients with diabetes. ( Nakazawa, T; Nishida, K; Shimura, M; Yasuda, K, 2007) |
| " Because administration of nonsteroidal eyedrops such as diclofenac seems to prevent the adverse effects of latanoprost therapy while maintaining its effect to lower intraocular pressure, we suggest their concurrent application." | 9.09 | Latanoprost accelerates disruption of the blood-aqueous barrier and the incidence of angiographic cystoid macular edema in early postoperative pseudophakias. ( Ichihashi, S; Maekubo, K; Miyake, K; Miyake, S; Ota, I, 1999) |
| " The concurrent administration of nonsteroidal anti-inflammatory drug such as diclofenac prevents these adverse effects without interfering with the drop in intraocular pressure caused by timolol." | 9.09 | Enhanced disruption of the blood-aqueous barrier and the incidence of angiographic cystoid macular edema by topical timolol and its preservative in early postoperative pseudophakia. ( Akura, J; Ibaraki, N; Ichihashi, S; Maekubo, K; Miyake, K; Miyake, S; Ota, I; Shibuya, Y, 2001) |
| "To evaluate the effectiveness of diclofenac eyedrops in reducing inflammation and the incidence of angiographic cystoid macular edema (CME) after cataract surgery and intraocular lens (IOL) implantation." | 9.08 | Effectiveness of diclofenac eyedrops in reducing inflammation and the incidence of cystoid macular edema after cataract surgery. ( Bujtar, E; Castoldi, D; Orzalesi, N; Rossetti, L; Torrazza, C, 1996) |
| "Diclofenac sodium was as effective as the control regimen in controlling postoperative inflammation after cataract surgery." | 9.08 | Efficacy of diclofenac eyedrops in preventing postoperative inflammation and long-term cystoid macular edema. Italian Diclofenac Study Group. ( , 1997) |
| "1% fluorometholone) in preventing cystoid macular edema (CME) and inducing disruption of the blood-aqueous barrier determined by laser flare cellmetry." | 9.08 | [Preventive effects of diclofenac ophthalmic solution on post-cataract-surgical cystoid macular edema]. ( Eguchi, K; Hayashi, F; Hoshi, H; Kimura, W; Majima, Y; Masuda, K; Miyake, K; Oshika, T; Shirato, S, 1998) |
| "Intravitreal diclofenac (IVD) may be a promising treatment for refractory uveitis-associated CME." | 7.88 | Intravitreal diclofenac for treatment of refractory uveitis-associated cystoid macular oedema: A before and after clinical study. ( Kianersi, F; Kianersi, H; Pourazizi, M; Rezaeian-Ramsheh, A, 2018) |
| "1 mL of intravitreal diclofenac under aseptic conditions and followed up for 3 months with respect to best-corrected visual acuity (BCVA), intraocular pressure (IOP), fundus fluorescein angiography, and CMT measured on OCT." | 7.83 | Intravitreal Diclofenac in the Treatment of Macular Edema Due to Branch Retinal Vein Occlusion. ( Arora, S; Ghosh, B; Gupta, A; Raina, UK; Seth, A, 2016) |
| "Diclofenac was more effective than betamethasone in preventing angiographic CME and BAB disruption after small-incision cataract surgery." | 6.73 | Reducing angiographic cystoid macular edema and blood-aqueous barrier disruption after small-incision phacoemulsification and foldable intraocular lens implantation: multicenter prospective randomized comparison of topical diclofenac 0.1% and betamethason ( Asano, S; Kimura, W; Miyake, K; Ota, I; Sakka, Y; Sugita, G; Yabe, N, 2008) |
| "The addition of diclofenac or bromfenac ophthalmic solutions contributed to further reduce both inflammation and cystoid macular edema after cataract surgery compared to steroid-antibiotic combination alone." | 5.27 | The Comparative Efficacy and Tolerability of Diclofenac 0.1% and Bromfenac 0.09% Ophthalmic Solutions after Cataract Surgery. ( Campos, EC; Finzi, A; Giannaccare, G; Greco, F; Sebastiani, S; Versura, P, 2018) |
| "Patients preoperatively treated with diclofenac had significantly lower intraocular levels of IL-12 and a lower increase in CFT, which indicates that a combination of preoperative and postoperative treatment with a topical NSAID may lower the incidence of postoperative macular edema in patients with diabetic retinopathy." | 5.24 | Effect of preoperative topical diclofenac on intraocular interleukin-12 concentration and macular edema after cataract surgery in patients with diabetic retinopathy: a randomized controlled trial. ( Jukić, T; Matas, A; Medić, A; Sapunar, A; Vukojević, K; Znaor, L, 2017) |
| "The purpose of the study is to compare single injection of intravitreal diclofenac (IVD) with intravitreal bevacizumab (IVB) in the treatment of eyes with naïve diabetic macular edema (DME)." | 5.20 | Intravitreal diclofenac versus intravitreal bevacizumab in naive diabetic macular edema: a randomized double-masked clinical trial. ( Karimi, S; Montahai, T; Peyman, GA; Ramezani, A; Soheilian, M; Soheilian, R; Yaseri, M, 2015) |
| "To compare the effect of intravitreal diclofenac (IVD) versus intravitreal triamcinolone (IVT) on refractory uveitic cystoid macular edema (CME)." | 5.17 | A pilot study of intravitreal diclofenac versus intravitreal triamcinolone for uveitic cystoid macular edema. ( Eskandari, A; Rabbanikhah, Z; Ramezani, A; Soheilian, M; Soheilian, R, 2013) |
| "To compare the efficacy and safety of intravitreal diclofenac versus intravitreal triamcinolone acetonide in the treatment of diabetic macular edema." | 5.15 | Intravitreal diclofenac versus intravitreal triamcinolone acetonide in the treatment of diabetic macular edema. ( Elbendary, AM; Shahin, MM, 2011) |
| "The purpose of this study was to evaluate the effect of a single dose of intravitreal diclofenac, a potent nonsteroidal antiinflammatory drug, on visual acuity and central macular thickness in patients with macular edema of various etiologies." | 5.14 | Pilot study of intravitreal injection of diclofenac for treatment of macular edema of various etiologies. ( Karimi, S; Peyman, GA; Ramezani, A; Soheilian, M, 2010) |
| "Although NSAID therapy seems to potentiate the improvements produced by corticosteroids and antivascular endothelial growth factor therapy for chronic pseudophakic cystoid macular edema, only nepafenac- and bromfenac-treated eyes showed reduced retinal thickness at 12 weeks and 16 weeks." | 5.14 | NSAIDs in combination therapy for the treatment of chronic pseudophakic cystoid macular edema. ( Bahrani, H; Fox, JE; Warren, KA, 2010) |
| "This study compares the effect of topical diclofenac with that of betamethasone against postoperative cystoid macular edema (CME) following cataract surgery in patients with non- and mild nonproliferative diabetic retinopathy." | 5.12 | Diclofenac prevents an early event of macular thickening after cataract surgery in patients with diabetes. ( Nakazawa, T; Nishida, K; Shimura, M; Yasuda, K, 2007) |
| " Because administration of nonsteroidal eyedrops such as diclofenac seems to prevent the adverse effects of latanoprost therapy while maintaining its effect to lower intraocular pressure, we suggest their concurrent application." | 5.09 | Latanoprost accelerates disruption of the blood-aqueous barrier and the incidence of angiographic cystoid macular edema in early postoperative pseudophakias. ( Ichihashi, S; Maekubo, K; Miyake, K; Miyake, S; Ota, I, 1999) |
| " The concurrent administration of nonsteroidal anti-inflammatory drug such as diclofenac prevents these adverse effects without interfering with the drop in intraocular pressure caused by timolol." | 5.09 | Enhanced disruption of the blood-aqueous barrier and the incidence of angiographic cystoid macular edema by topical timolol and its preservative in early postoperative pseudophakia. ( Akura, J; Ibaraki, N; Ichihashi, S; Maekubo, K; Miyake, K; Miyake, S; Ota, I; Shibuya, Y, 2001) |
| "To evaluate the effectiveness of diclofenac eyedrops in reducing inflammation and the incidence of angiographic cystoid macular edema (CME) after cataract surgery and intraocular lens (IOL) implantation." | 5.08 | Effectiveness of diclofenac eyedrops in reducing inflammation and the incidence of cystoid macular edema after cataract surgery. ( Bujtar, E; Castoldi, D; Orzalesi, N; Rossetti, L; Torrazza, C, 1996) |
| "Diclofenac sodium was as effective as the control regimen in controlling postoperative inflammation after cataract surgery." | 5.08 | Efficacy of diclofenac eyedrops in preventing postoperative inflammation and long-term cystoid macular edema. Italian Diclofenac Study Group. ( , 1997) |
| "1% fluorometholone) in preventing cystoid macular edema (CME) and inducing disruption of the blood-aqueous barrier determined by laser flare cellmetry." | 5.08 | [Preventive effects of diclofenac ophthalmic solution on post-cataract-surgical cystoid macular edema]. ( Eguchi, K; Hayashi, F; Hoshi, H; Kimura, W; Majima, Y; Masuda, K; Miyake, K; Oshika, T; Shirato, S, 1998) |
| "Intravitreal diclofenac (IVD) may be a promising treatment for refractory uveitis-associated CME." | 3.88 | Intravitreal diclofenac for treatment of refractory uveitis-associated cystoid macular oedema: A before and after clinical study. ( Kianersi, F; Kianersi, H; Pourazizi, M; Rezaeian-Ramsheh, A, 2018) |
| "1 mL of intravitreal diclofenac under aseptic conditions and followed up for 3 months with respect to best-corrected visual acuity (BCVA), intraocular pressure (IOP), fundus fluorescein angiography, and CMT measured on OCT." | 3.83 | Intravitreal Diclofenac in the Treatment of Macular Edema Due to Branch Retinal Vein Occlusion. ( Arora, S; Ghosh, B; Gupta, A; Raina, UK; Seth, A, 2016) |
| "Diclofenac was the most likely to reduce the odds of developing CME compared with bromfenac and nepafenac." | 3.01 | Comparison of the efficacy and safety of non-steroidal anti-inflammatory drugs and corticosteroid drugs for prevention of cystoid macular edema after cataract surgery. ( Chen, X; Li, SS; Wang, HH; Wang, YL; Zhang, DW, 2023) |
| "Diclofenac was more effective than betamethasone in preventing angiographic CME and BAB disruption after small-incision cataract surgery." | 2.73 | Reducing angiographic cystoid macular edema and blood-aqueous barrier disruption after small-incision phacoemulsification and foldable intraocular lens implantation: multicenter prospective randomized comparison of topical diclofenac 0.1% and betamethason ( Asano, S; Kimura, W; Miyake, K; Ota, I; Sakka, Y; Sugita, G; Yabe, N, 2008) |
| "Initial angiographic cystoid macular edema was comparable and significantly improved after therapy in the two treatment groups." | 2.67 | [Differential treatment of postoperative and uveitis-induced inflammatory cystoid macular edema]. ( Guex-Crosier, Y; Herbort, CP; Othenin-Girard, P, 1992) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (5.56) | 18.7374 |
| 1990's | 6 (16.67) | 18.2507 |
| 2000's | 5 (13.89) | 29.6817 |
| 2010's | 21 (58.33) | 24.3611 |
| 2020's | 2 (5.56) | 2.80 |
| Authors | Studies |
|---|---|
| Li, SS | 1 |
| Wang, HH | 1 |
| Wang, YL | 1 |
| Zhang, DW | 1 |
| Chen, X | 1 |
| Wingert, AM | 2 |
| Liu, SH | 2 |
| Lin, JC | 2 |
| Sridhar, J | 2 |
| Ylinen, P | 2 |
| Holmström, E | 2 |
| Laine, I | 2 |
| Lindholm, JM | 2 |
| Tuuminen, R | 2 |
| Kianersi, F | 2 |
| Rezaeian-Ramsheh, A | 1 |
| Pourazizi, M | 1 |
| Kianersi, H | 1 |
| Giannaccare, G | 1 |
| Finzi, A | 1 |
| Sebastiani, S | 1 |
| Greco, F | 1 |
| Versura, P | 1 |
| Campos, EC | 1 |
| Taipale, C | 1 |
| Soheilian, M | 3 |
| Eskandari, A | 1 |
| Ramezani, A | 4 |
| Rabbanikhah, Z | 1 |
| Soheilian, R | 2 |
| Jin Choi, H | 1 |
| Moyer, K | 1 |
| DeWilde, A | 1 |
| Law, C | 1 |
| Karimi, S | 2 |
| Montahai, T | 1 |
| Yaseri, M | 2 |
| Peyman, GA | 2 |
| Gaskin, JC | 1 |
| Coote, M | 1 |
| Lee, TH | 1 |
| Choi, W | 1 |
| Ji, YS | 1 |
| Yoon, KC | 1 |
| Shorstein, NH | 1 |
| Liu, L | 1 |
| Waxman, MD | 1 |
| Herrinton, LJ | 1 |
| Seth, A | 1 |
| Ghosh, B | 1 |
| Raina, UK | 1 |
| Gupta, A | 1 |
| Arora, S | 1 |
| Entezari, M | 1 |
| Nikkhah, H | 1 |
| Ghanbari, H | 1 |
| Sonbolestan, SA | 1 |
| Abtahi, MA | 1 |
| Akbari, M | 1 |
| Abtahi, ZA | 1 |
| Abtahi, SH | 1 |
| Medić, A | 1 |
| Jukić, T | 1 |
| Matas, A | 1 |
| Vukojević, K | 1 |
| Sapunar, A | 1 |
| Znaor, L | 1 |
| Warren, KA | 1 |
| Bahrani, H | 1 |
| Fox, JE | 1 |
| Elbendary, AM | 1 |
| Shahin, MM | 1 |
| Romac, I | 1 |
| Gabrić, N | 1 |
| Dekaris, I | 1 |
| Barisić, A | 1 |
| Gallego-Pinazo, R | 1 |
| Martínez Castillo, S | 1 |
| Dolz-Marco, R | 1 |
| Lleó-Pérez, A | 1 |
| Díaz-Llopis, M | 1 |
| Kim, SJ | 1 |
| Rho, DS | 1 |
| Shimura, M | 1 |
| Nakazawa, T | 1 |
| Yasuda, K | 1 |
| Nishida, K | 1 |
| Miyake, K | 6 |
| Nishimura, K | 1 |
| Harino, S | 1 |
| Ota, I | 4 |
| Asano, S | 2 |
| Kondo, N | 1 |
| Miyake, S | 3 |
| Sugita, G | 1 |
| Kimura, W | 2 |
| Sakka, Y | 1 |
| Yabe, N | 1 |
| Gills, JP | 1 |
| Rossetti, L | 1 |
| Bujtar, E | 1 |
| Castoldi, D | 1 |
| Torrazza, C | 1 |
| Orzalesi, N | 1 |
| Masuda, K | 2 |
| Shirato, S | 1 |
| Oshika, T | 1 |
| Eguchi, K | 1 |
| Hoshi, H | 1 |
| Majima, Y | 1 |
| Hayashi, F | 1 |
| Maekubo, K | 2 |
| Ichihashi, S | 2 |
| Ibaraki, N | 1 |
| Akura, J | 1 |
| Shibuya, Y | 1 |
| Guex-Crosier, Y | 1 |
| Othenin-Girard, P | 1 |
| Herbort, CP | 1 |
| Mishima, H | 1 |
| Quentin, CD | 1 |
| Behrens-Baumann, W | 1 |
| Gaus, W | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Evaluating the Efficacy, Compliance, and Patient Satisfaction of a New Dropless Postoperative Regimen After Cataract Surgery in a Vulnerable, County-hospital Population[NCT05157113] | Phase 4 | 70 participants (Anticipated) | Interventional | 2022-05-31 | Recruiting | ||
| A Randomised Control Study to Investigate if the Continuation of Prostaglandin Analogue Treatments in the Post-operative Phase of Glaucoma Patients Undergoing Cataract Surgery Increases the Incidence of Cystoid Macular Oedema.[NCT03292796] | Phase 2 | 56 participants (Actual) | Interventional | 2016-12-07 | Completed | ||
| Evaluation of Macular Thickness in Patients With Glaucoma in Use of Topical Prostaglandin Analogue Undergoing Trabeculectomy With Mitomycin C[NCT06000280] | 37 participants (Actual) | Interventional | 2021-01-04 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
3 reviews available for diclofenac and Macular Edema
| Article | Year |
|---|---|
Comparison of the efficacy and safety of non-steroidal anti-inflammatory drugs and corticosteroid drugs for prevention of cystoid macular edema after cataract surgery.
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Betamethasone; Cataract; Cataract | 2023 |
Non-steroidal anti-inflammatory agents for treating cystoid macular edema following cataract surgery.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Cataract; Diclofenac; Female; Humans; Ketorolac; Macu | 2022 |
Non-steroidal anti-inflammatory agents for treating cystoid macular edema following cataract surgery.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Cataract; Diclofenac; Female; Humans; Ketorolac; Macu | 2022 |
Non-steroidal anti-inflammatory agents for treating cystoid macular edema following cataract surgery.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Cataract; Diclofenac; Female; Humans; Ketorolac; Macu | 2022 |
Non-steroidal anti-inflammatory agents for treating cystoid macular edema following cataract surgery.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Cataract; Diclofenac; Female; Humans; Ketorolac; Macu | 2022 |
The putative role of prostaglandins in cystoid macular edema.
Topics: Aqueous Humor; Cataract Extraction; Diclofenac; Fluorescein Angiography; Flurbiprofen; Humans; Indom | 1989 |
20 trials available for diclofenac and Macular Edema
| Article | Year |
|---|---|
The Comparative Efficacy and Tolerability of Diclofenac 0.1% and Bromfenac 0.09% Ophthalmic Solutions after Cataract Surgery.
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Benzophenones; Bromobenzenes; Cata | 2018 |
A pilot study of intravitreal diclofenac versus intravitreal triamcinolone for uveitic cystoid macular edema.
Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Female; Follow-Up Stud | 2013 |
Intravitreal diclofenac versus intravitreal bevacizumab in naive diabetic macular edema: a randomized double-masked clinical trial.
Topics: Adult; Aged; Analysis of Variance; Angiogenesis Inhibitors; Anti-Inflammatory Agents, Non-Steroidal; | 2015 |
The effect of topical sodium diclofenac on macular thickness in diabetic eyes after phacoemulsification: a randomized controlled trial.
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Diabetic Retinopathy; Diclofenac; | 2017 |
Intravitreal Diclofenac plus Bevacizumab versus Bevacizumab alone in treatment-naive diabetic macular edema: a randomized double-blind clinical trial.
Topics: Angiogenesis Inhibitors; Anti-Inflammatory Agents, Non-Steroidal; Bevacizumab; Diabetic Retinopathy; | 2017 |
Effect of preoperative topical diclofenac on intraocular interleukin-12 concentration and macular edema after cataract surgery in patients with diabetic retinopathy: a randomized controlled trial.
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Antibiotic Prophylaxis; Aqueous Hu | 2017 |
Pilot study of intravitreal injection of diclofenac for treatment of macular edema of various etiologies.
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Electroretinography; F | 2010 |
NSAIDs in combination therapy for the treatment of chronic pseudophakic cystoid macular edema.
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Anti-Inflammatory Agents, Non-Steroidal; Antibodie | 2010 |
Intravitreal diclofenac versus intravitreal triamcinolone acetonide in the treatment of diabetic macular edema.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Diabetic Retinopathy; Diclofenac; Female; Glucocorti | 2011 |
Treatment of acute pseudophakic cystoid macular edema: Diclofenac versus ketorolac.
Topics: Administration, Topical; Aged; Cyclooxygenase Inhibitors; Diclofenac; Drug Evaluation; Female; Human | 2003 |
Diclofenac prevents an early event of macular thickening after cataract surgery in patients with diabetes.
Topics: Administration, Topical; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Anti-Inflammatory Agents | 2007 |
The effect of topical diclofenac on choroidal blood flow in early postoperative pseudophakias with regard to cystoid macular edema formation.
Topics: Administration, Topical; Aged; Anti-Inflammatory Agents, Non-Steroidal; Blood Flow Velocity; Blood-A | 2007 |
Reducing angiographic cystoid macular edema and blood-aqueous barrier disruption after small-incision phacoemulsification and foldable intraocular lens implantation: multicenter prospective randomized comparison of topical diclofenac 0.1% and betamethason
Topics: Administration, Topical; Aged; Anti-Inflammatory Agents, Non-Steroidal; Betamethasone; Blood-Aqueous | 2008 |
Effectiveness of diclofenac eyedrops in reducing inflammation and the incidence of cystoid macular edema after cataract surgery.
Topics: Administration, Topical; Aged; Anterior Chamber; Anti-Inflammatory Agents, Non-Steroidal; Cataract E | 1996 |
Efficacy of diclofenac eyedrops in preventing postoperative inflammation and long-term cystoid macular edema. Italian Diclofenac Study Group.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Cataract Extraction; Diclofenac; Double-Blind Method; | 1997 |
[Preventive effects of diclofenac ophthalmic solution on post-cataract-surgical cystoid macular edema].
Topics: Aged; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Blood-Aqueous Barrier; Cata | 1998 |
Latanoprost accelerates disruption of the blood-aqueous barrier and the incidence of angiographic cystoid macular edema in early postoperative pseudophakias.
Topics: Aged; Blood-Aqueous Barrier; Cataract Extraction; Diclofenac; Double-Blind Method; Female; Fluoresce | 1999 |
Enhanced disruption of the blood-aqueous barrier and the incidence of angiographic cystoid macular edema by topical timolol and its preservative in early postoperative pseudophakia.
Topics: Administration, Topical; Adrenergic beta-Antagonists; Aged; Anterior Eye Segment; Anti-Inflammatory | 2001 |
[Differential treatment of postoperative and uveitis-induced inflammatory cystoid macular edema].
Topics: Acetazolamide; Adult; Aged; Aged, 80 and over; Diclofenac; Female; Humans; Injections; Lenses, Intra | 1992 |
[Prevention of cystoid macular edema with diclofenac eyedrops in intracapsular cataract extraction using the Choyce Mark IX anterior chamber lens].
Topics: Aged; Diclofenac; Double-Blind Method; Female; Humans; Lenses, Intraocular; Macular Edema; Male; Oph | 1989 |
13 other studies available for diclofenac and Macular Edema
| Article | Year |
|---|---|
Anti-inflammatory medication following cataract surgery: a randomized trial between preservative-free dexamethasone, diclofenac and their combination.
Topics: Aged; Anti-Inflammatory Agents; Cataract Extraction; Dexamethasone; Diclofenac; Dose-Response Relati | 2018 |
Intravitreal diclofenac for treatment of refractory uveitis-associated cystoid macular oedema: A before and after clinical study.
Topics: Adolescent; Adult; Cyclooxygenase Inhibitors; Diclofenac; Dose-Response Relationship, Drug; Fluoresc | 2018 |
Postoperative management in cataract surgery: nepafenac and preservative-free diclofenac compared.
Topics: Administration, Topical; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Benzeneac | 2018 |
Corneal edema and cystoid macular edema by nuclear fragments after uneventful phacoemulsification.
Topics: Acetazolamide; Aged; Anterior Eye Segment; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-S | 2013 |
Cystoid macular edema from cancer-associated retinopathy.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Drug Therapy, Combination; Fluorescein An | 2014 |
Postoperative cystoid macular oedema in a patient on fingolimod.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Cataract Extraction; Diclofenac; Female; Fingolimod Hydroch | 2015 |
Comparison of ketorolac 0.45% versus diclofenac 0.1% for macular thickness and volume after uncomplicated cataract surgery.
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Female; Humans; Intrao | 2016 |
Comparative Effectiveness of Three Prophylactic Strategies to Prevent Clinical Macular Edema after Phacoemulsification Surgery.
Topics: Administration, Topical; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Diclofena | 2015 |
Intravitreal Diclofenac in the Treatment of Macular Edema Due to Branch Retinal Vein Occlusion.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Female; Fluorescein Angiography; F | 2016 |
Resolution of pseudophakic cystoid macular edema with combination therapy of topical corticosteroids and nonsteroidal anti-inflammatory drugs.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Dexamethasone; Diclofenac; Drug Therapy, Combination; | 2011 |
[Analysis of prognostic factors by spectral-domain optical coherence tomography in pseudophakic cystoid macular oedema].
Topics: Acetazolamide; Aged; Anti-Inflammatory Agents; Diclofenac; Female; Humans; Macular Edema; Male; Post | 2012 |
“Intravitreal diclofenac versus intravitreal triamcinolone acetonide in the treatment of diabetic macular edema”.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Diabetic Retinopathy; Diclofenac; Female; Glucocorticoids; | 2012 |
Voltaren associated with medication keratitis.
Topics: Diclofenac; Drug Hypersensitivity; Humans; Keratitis; Macular Edema | 1994 |